Months after the FDA told healthcare facilities to avoid plastic syringes made in China because of leaking issues, four companies have recently recalled products. Since November 2023, the FDA has ...
The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.
(RTTNews) - The U.S. Food and Drug Administration said Thursday that it is evaluating plastic syringes made in China for potential device failures, such as leaks, breakage, and other problems. However ...
Lest this week’s news about FDA cautioning against the use of plastic syringes made in China raise concerns of a possible shortage, BD announced today that it is increasing its US production of ...
The FDA last week re-upped its recommendations that healthcare providers avoid using plastic syringes made in China wherever possible, while it continues to investigate growing quality concerns. In ...
FDA recently issued a safety communication informing consumers of potential device failures with plastic syringes manufactured in China. “We are concerned that certain syringes manufactured in China ...
June 14 (Reuters) - The U.S. Food and Drug Administration said on Friday that Merit Medical Systems (MMSI.O), opens new tab has initiated a recall for unapproved plastic syringes supplied by ...
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it is looking into reports of leaks, breakages ...
The U.S. Food and Drug Administration (FDA) on Thursday said it was assessing plastic syringes made in China for potential device failures such as leaks or breakages. The FDA added that it was aware ...
Medline and Jiangsu Shenli Medical Production Co. have initiated recalls of plastic syringes amid reports of them breaking and leaking, the FDA confirmed in late May. The two companies have recalled ...
BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...
Mainz, Germany-based pharmaceutical container and delivery system supplier Schott Pharma AG & Co. is investing $371 million in Wilson, N.C., for a plant to manufacture prefillable plastic syringes.